Picilorex
Tools
Actions
General
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
Chemical compound
![]() | |
Clinical data | |
---|---|
Other names | UP 507-04 |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H18ClN |
Molar mass | 235.76 g·mol−1 |
3D model (JSmol) | |
| |
|
Picilorex (INN; brand name Roxenan; IUPAC: 3-(4-Chlorophenyl)-5-cyclopropyl-2-methylpyrrolidine)[1] is an anorectic which is no longer marketed.[2][3][4] It is a monoamine reuptake inhibitor, a stimulant as well as a derivate of Pyrrolidine.[3]
See also
[edit]- α-PHP
- α-PHPP
- Pyrovalerone
- Prolintane
- Rolicyclidine (PCPy)
- MDPV
- List of aminorex analogues
- Substituted phenylmorpholine
References
[edit]- ^ PubChem. "Cyclopropyl-2 p-chlorophenyl-4 methyl-5 pyrrolidine succinate". pubchem.ncbi.nlm.nih.gov. Archived from the original on 2021-05-31. Retrieved 2021-05-31.
- ^ Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 1599–. ISBN 978-0-412-46630-4.
- ^ a b Milne GW (1 January 2001). Ashgate Handbook of Autonomic Nervous System Agents. Wiley. ISBN 978-0-566-08384-6.
- ^ World Health Organization (2000). International Nonproprietary Names (INN) for Pharmaceutical Substances. World Health Organization. ISBN 978-0-11-986227-0. Archived from the original on 2019-07-14. Retrieved 2016-10-16.
Adamantanes | |
---|---|
Adenosine antagonists | |
Alkylamines | |
Ampakines | |
Arylcyclohexylamines | |
Benzazepines | |
Cathinones |
|
Cholinergics |
|
Convulsants | |
Eugeroics | |
Oxazolines | |
Phenethylamines |
|
Phenylmorpholines | |
Piperazines | |
Piperidines |
|
Pyrrolidines | |
Racetams | |
Tropanes |
|
Tryptamines | |
Others |
|
α1 |
| ||||
---|---|---|---|---|---|
α2 |
| ||||
β |
| ||||
D1-like |
| ||||||
---|---|---|---|---|---|---|---|
D2-like |
| ||||||
![]() | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |